VITR logo

Vitrolife AB (publ) Stock Price

OM:VITR Community·SEK 19.2b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 5 Fair Values set on narratives written by author
Create a narrative

VITR Share Price Performance

SEK 141.70
-96.50 (-40.51%)
30.0% undervalued intrinsic discount
SEK 202.50
Fair Value
SEK 141.70
-96.50 (-40.51%)
30.0% undervalued intrinsic discount
SEK 202.50
Fair Value
Price SEK 141.70
AnalystConsensusTarget SEK 202.50

VITR Community Narratives

AnalystConsensusTarget·
Fair Value SEK 202.5 30.0% undervalued intrinsic discount

US IVF Treatment Rebound And APAC Reimbursements Will Drive Recovery

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative

Recent VITR News & Updates

Vitrolife AB (publ)'s (STO:VITR) Shares Lagging The Industry But So Is The Business

Aug 25
Vitrolife AB (publ)'s (STO:VITR) Shares Lagging The Industry But So Is The Business
User avatar

US IVF Treatment Rebound And APAC Reimbursements Will Drive Recovery

Recovery in IVF procedure volume and expansion in key regions will drive organic revenue growth and margin improvement as market conditions stabilize.

Vitrolife AB (publ)'s (STO:VITR) Intrinsic Value Is Potentially 68% Above Its Share Price

Jul 08
Vitrolife AB (publ)'s (STO:VITR) Intrinsic Value Is Potentially 68% Above Its Share Price

Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Jun 20
Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Apr 25
Vitrolife AB (publ)'s (STO:VITR) Price Is Right But Growth Is Lacking

Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Mar 13
Here's Why Vitrolife (STO:VITR) Can Manage Its Debt Responsibly

Vitrolife AB (publ) Key Details

SEK 3.5b

Revenue

SEK 1.5b

Cost of Revenue

SEK 2.1b

Gross Profit

SEK 1.6b

Other Expenses

SEK 455.0m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 23, 2025
Earnings per share (EPS)
3.36
Gross Margin
58.85%
Net Profit Margin
12.85%
Debt/Equity Ratio
14.1%

Vitrolife AB (publ) Competitors

 
 
 
 
 
 
 
 
 
 
 
 
View more competitors

Snowflake Analysis

Reasonable growth potential with adequate balance sheet.

0 Risks
3 Rewards
View Full Analysis

About VITR

Founded
1989
Employees
1147
CEO
Bronwyn Brophy O´Connor
WebsiteView website
www.vitrolife.com

Vitrolife AB (publ) provides assisted reproduction products in Europe, the Middle East, Africa, Asia-Pacific, and the Americas. It offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. The company also provides eWitness and Labware products, such as dishes, pipettes, tubes, and VitroTemp. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.

Market Insight

Header cover image

✨Rare Earths: Tiny Market, Outsized Influence

Richard Bowman avatarRichard Bowman
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Last Week
⚡ Utilities: Defensive Dividends Meet the AI Power Surge

⚡ Utilities: Defensive Dividends Meet the AI Power Surge

Swedish Market Performance

  • 7 Days: 2.9%
  • 3 Months: 3.6%
  • 1 Year: -0.4%
  • Year to Date: 3.6%
Over the last 7 days, the market has risen 2.5%, driven by gains of 3.5% in the Industrials sector. As for last year, the market performance has been flat. Earnings are forecast to grow by 16% annually. Market details ›